BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3346363)

  • 1. Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
    Scoccia B; Schneider AB; Marut EL; Scommegna A
    J Clin Endocrinol Metab; 1988 Apr; 66(4):868-71. PubMed ID: 3346363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactinomas in women treated in the past for infertility.
    Farine D; Ben-Rafael Z; Oelsner G; Serr DM; Lunenfeld B; Goldhammer Y; Tadmor R; Mashiach S
    Int J Fertil; 1983; 28(2):96-9. PubMed ID: 6136483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naval aviator with pituitary prolactin secreting microadenoma: case report and aeromedical concerns.
    Weiss DK
    Aviat Space Environ Med; 2000 Sep; 71(9):935-8. PubMed ID: 11001348
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia in postmenopausal women.
    Maor Y; Berezin M
    Fertil Steril; 1997 Apr; 67(4):693-6. PubMed ID: 9093196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
    Mahler C; Verhelst J; Klaes R; Trouillas J
    Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperprolactinemia: importance of early therapy].
    Rachidi-Koussa H; Vergely N; Duthel R; Malluret J; Estour B
    Presse Med; 1994 Nov; 23(36):1669. PubMed ID: 7899295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prolactinomas and "idiopathic" hyperprolactinemia. Case series].
    Volpe A; Grasso A; Oliva A; Bramanti P; Leggiadro N; Musolino R; Meduri M
    Riv Neurol; 1980; 50(5):350-61. PubMed ID: 6781058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
    Sabakhtarashvili MA; Veĭnberg EG; Kurashvili RB; Kanchaveli ZSh
    Akush Ginekol (Mosk); 1989 Oct; (10):50-4. PubMed ID: 2618957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonists for reducing depression associated with hyperprolactinemia.
    Mattox JH; Buckman MT; Bernstein J; Pathak D; Kellner R
    J Reprod Med; 1986 Aug; 31(8):694-8. PubMed ID: 3772890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of hyperprolactinemia with pergolide.
    Mattox JH; Bernstein J; Buckman MT
    Int J Fertil; 1986; 30(4):39-43. PubMed ID: 2890594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the role of bromocriptine in the primary treatment of prolactinomas.
    Lamberts SW
    Neth J Med; 1988 Apr; 32(3-4):107-11. PubMed ID: 3362264
    [No Abstract]   [Full Text] [Related]  

  • 15. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
    Cremonini N; Graziano E; Chiarini V; Sforza A; Zampa GA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1166-9. PubMed ID: 1400888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of hyperprolactinemia.
    Fossati P; Dewailly D; Thomas-Desrousseaux P; Buvat J; Fermon C; Lemaire A; Bourdelle-Hego MF; Pouyol-Motte H; Lemaitre G; Clarisse J
    Horm Res; 1985; 22(3):228-38. PubMed ID: 4054843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia in nonpregnant women due to pituitary tumors.
    Tolstoi LG
    Life Sci; 1986 Jun; 38(22):1981-9. PubMed ID: 3012232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinaemia and pituitary adenomas in adolescence.
    Dissaneevate P; Warne GL
    J Pediatr Endocrinol Metab; 1998; 11(4):531-41. PubMed ID: 9777574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.